Company / Return on Assets (ROA)
Adaptimmune Therapeutics PLC Return on Assets (ROA) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-28.8%
FY2024
5-year range
-50.3% / -28.8%
FY2020-FY2024
Trend
+28.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -75.6% in FY2019 to -24.9% in FY2017.
Based on SEC 10-K filings.
-28.8% in FY2024 with a 5-year CAGR of +46.8%.
Improved from -50.3% to -28.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +4.9pp
- 5-Year Change
- +46.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 28.5% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -28.8% | +28.5% |
| FY2023 | -40.3% | +19.9% |
| FY2022 | -50.3% | -49.4% |
| FY2021 | -33.7% | -16.7% |
| FY2020 | -28.8% | +61.8% |
| FY2019 | -75.6% | -119.0% |
| FY2018 | -34.5% | -38.3% |
| FY2017 | -24.9% | +18.3% |
| FY2016 | -30.5% | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026